SCHEMBL6002896

SCHEMBL6002896

FC(F)(F)OC1(c2ccccc2)CNCC[N]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.38
TACR1 P25103 8/20 0.33
SLC6A4 P31645 4/20 0.33
OPRM1 P35372 1/20 0.33
CACNA1F O60840 1/20 0.31
AR P10275 1/20 0.31
PDE4A P27815 1/20 0.31
SCN1A P35498 1/20 0.31
SCN4A P35499 1/20 0.31
SCN7A Q01118 1/20 0.31
CACNA1D Q01668 1/20 0.31
KCNH2 Q12809 1/20 0.31
CACNA1S Q13698 1/20 0.31
CACNA1C Q13936 1/20 0.31
SCN5A Q14524 1/20 0.31
SCN9A Q15858 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
SCN11A Q9UI33 1/20 0.31
SCN8A Q9UQD0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1255254 0.80 HTR2A (0.41) HTR2ATACR1OPRM1CACNA1FAR
SCHEMBL4722907 0.76 OPRM1 (0.38) HTR2ATACR1OPRM1
SCHEMBL4720205 0.74 OPRM1 (0.36) HTR2AOPRM1
SCHEMBL1255270 0.73 HTR2A (0.41) HTR2ATACR1SLC6A4OPRM1CACNA1F
SCHEMBL4723024 0.71 USP2 (0.40) HTR2AOPRM1
SCHEMBL10430315 0.71 HTR2A (0.39) HTR2ATACR1SLC6A4OPRM1
SCHEMBL4436585 0.70 HTR2A (0.44) HTR2AOPRM1CACNA1FARPDE4A
SCHEMBL654291 0.70 HTR2A (0.47) HTR2AOPRM1CACNA1FARPDE4A
SCHEMBL10682672 0.67 HTR2A (0.44) HTR2ASLC6A4OPRM1CACNA1FAR
SCHEMBL1254663 0.67 HTR2A (0.44) HTR2AOPRM1CACNA1FARPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed